Ms. Alison Silva
PRESIDENT AND CHIEF EXECUTIVE OFFICER
biopharmaceutical
Critical Outcome Technologies
United States of America
Biography
Alison Silva is the President, Chief Executive Officer and a Director of Critical Outcome Technologies, Inc. Previously, she was a co‐founder, Executive Vice President and Chief Operating Officer at Synlogic, Inc. where she lead the regulatory strategy, drug development, and operational aspects of the company’s focus on the discovery and development of engineered therapeutic probiotics
Research Interest
oncology
